A cannabinoid-based
biopharmaceutical company.
We are focused on drug discovery & personalized medicine derived from plant-based therapeutics and combination therapies.
The new frontier between medicine and botany.
1
AWARDED PATENT INHIBITING AUTOPHAGY TO PREVENT & TREAT CANCER
11
PROVISIONAL PATENT TO TREAT 11 CNS-RELATED VIRUSES & DISEASES*
15
15+ CELL STUDIES ONCOLOGY & ANTIVIRAL / CNS-RELATED VIRUSES & DISEASES
OUR PIPELINE
MEET TARGETED PHARMACEUTICALS
OUR VISION
Our goal is to bring precision medicine and real science to the cannabis industry by linking the molecular structure of humans to cannabinoid compounds.
DATA DRIVEN SOLUTIONS
Technology and data are at the core of what we do. We are very much a data-driven technology company focused on using data for personalized cannabinoid care.
TOP TEAM & ADVISORS FROM
TOP TEAM & ADVISORS FROM
George Mason University
National Cancer Institute
Harvard University
Worcester Polytechnic Institute
McLean Hospital
Food & Drug Adminstration
LATEST NEWS
Oct 22, 2020
Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19
-
Targeted Pharmaceuticals, Tetra Bio-Pharma and the George Mason University National Center for Biodefense and Infectious Diseases (NCBID) sign a research collaboration
-
ARDS-003 to be evaluated in Sars-CoV-2 infected animals at the Biocontainment Laboratory-George Mason University NCBID
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is excited to announce that it has signed a research collaboration agreement with Targeted Pharmaceutical and the George Mason University. The research is being conducted at the Biomedical Research Laboratory (BRL) which is managed by the George Mason University National Center for Biodefense and Infectious Diseases (NCBID)
GET
IN TOUCH
Targeted Pharmaceuticals
11 Apex Drive, Suite 300A
Marlborough, MA 01752
Targeted Pharmaceuticals is a cannabinoid-based drug discovery company.
Contact us today to learn more.
